Alliance Wealth Advisors (Utah)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,887
Closed -$1.04M 233
2025
Q4
$1.04M Sell
10,887
-5,673
-34% -$556K 0.22% 99
2025
Q3
$1.62M Buy
16,560
+11,178
+208% +$1.16M 0.38% 75
2025
Q2
$578K Sell
5,382
-67
-1% -$6.78K 0.14% 147
2025
Q1
$550K Sell
5,449
-4,651
-46% -$468K 0.14% 154
2024
Q4
$902K Sell
10,100
-4,886
-33% -$430K 0.23% 107
2024
Q3
$1.26M Buy
+14,986
New +$1.18M 0.33% 78

Other funds holding BSX

Alliance Wealth Advisors (Utah)'s BSX Position: Q1 2026 in Review

Alliance Wealth Advisors (Utah) sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 10,887 shares — an estimated $1.04M sold.

Alliance Wealth Advisors (Utah) first reported a position in BSX in Q3 2024 and held it in 6 quarters. The position peaked at $1.62M in Q3 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Alliance Wealth Advisors (Utah) reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Alliance Wealth Advisors (Utah) sold 10,887 Boston Scientific shares in Q1 2026, an estimated $1.04M.
  • Alliance Wealth Advisors (Utah) first reported a position in Boston Scientific in Q3 2024 and held it in 6 quarters.
  • Alliance Wealth Advisors (Utah)'s Boston Scientific position peaked at $1.62M in Q3 2025.
  • 1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Alliance Wealth Advisors (Utah)'s 13F filing for Q1 2026, filed 12 May 2026.